WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 10 fonti

Nvidia partners with Bristol-Myers Squibb to build AI supercomputer for drug discovery

Bristol-Myers Squibb and Nvidia built an AI supercomputer for drug discovery that cut computing costs 55%, joining a pharma industry AI infrastructure race.

Raccontata dabiopharmadive.comstatnews.comendpoints.newschannelnewsasia.comcryptobriefing.commorningstar.comeconomictimes.indiatimes.combenzinga.cominfobae.comhwupgrade.it

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
cryptobriefing.comStai leggendo2 g fa

Nvidia partners with Bristol-Myers Squibb to build AI supercomputer for drug discovery

Bristol-Myers Squibb and Nvidia built an AI supercomputer for drug discovery that cut computing costs 55%, joining a pharma industry AI infrastructure race.

originale

Timeline cronologica

  1. lunedì 20 luglio 2026·biopharmadive.com

    Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker

    Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.

  2. lunedì 20 luglio 2026·statnews.com

    Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer

    Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.

benzinga.com
2 g fa

Bristol Myers Squibb Supercharges Drug Discovery With NVIDIA AI - Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb adopts NVIDIA DGX SuperPOD to train next-gen AI models and accelerate drug discovery.

Leggi questa versione → originale
endpoints.news2 g fa

Bristol Myers says it will build pharma's 'most powerful' AI supercomputer with Nvidia

Bristol Myers says it will build biopharma's

Leggi questa versione → originale
economictimes.indiatimes.com2 g fa

Bristol Myers buys Nvidia's latest AI computing system for drug research - The Economic Times

Bristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery and development. The company expects to cycle through many more potential drug…

Leggi questa versione → originale
morningstar.com2 g fa

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Leggi questa versione → originale
channelnewsasia.com2 g fa

Bristol Myers buys Nvidia's latest AI computing system for drug research

NEW YORK, July 20 : Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence across its drug discovery and…

Leggi questa versione → originale
  • lunedì 20 luglio 2026·endpoints.news

    Bristol Myers says it will build pharma's 'most powerful' AI supercomputer with Nvidia

    Bristol Myers says it will build biopharma's

  • lunedì 20 luglio 2026·channelnewsasia.com

    Bristol Myers buys Nvidia's latest AI computing system for drug research

    NEW YORK, July 20 : Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence…

  • lunedì 20 luglio 2026·cryptobriefing.com

    Nvidia partners with Bristol-Myers Squibb to build AI supercomputer for drug discovery

    Bristol-Myers Squibb and Nvidia built an AI supercomputer for drug discovery that cut computing costs 55%, joining a pharma industry AI infrastructure race.

  • lunedì 20 luglio 2026·morningstar.com

    Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

    Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

  • lunedì 20 luglio 2026·economictimes.indiatimes.com

    Bristol Myers buys Nvidia's latest AI computing system for drug research - The Economic Times

    Bristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery and development. The company expects to…

  • lunedì 20 luglio 2026·benzinga.com

    Bristol Myers Squibb Supercharges Drug Discovery With NVIDIA AI - Bristol-Myers Squibb (NYSE:BMY)

    Bristol Myers Squibb adopts NVIDIA DGX SuperPOD to train next-gen AI models and accelerate drug discovery.

  • lunedì 20 luglio 2026·cryptobriefing.com

    Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory

    Bristol Myers Squibb expands its Nvidia AI factory partnership, reporting 55% cost savings on drug discovery workloads. Here's what it means for investors.

  • lunedì 20 luglio 2026·cryptobriefing.com

    Bristol Myers Squibb buys Nvidia's latest AI computing system for drug research

    Bristol Myers Squibb acquires Nvidia's Vera Rubin DGX SuperPOD for drug discovery, becoming the first pharma company to deploy the latest AI computing

  • mercoledì 22 luglio 2026·infobae.com

    Comienzan a construir una supercomputadora de IA: desarrollará medicamentos

    El nuevo clúster de cómputo de Nvidia y BMS se ubicará en los centros de datos de Equinix bajo un acuerdo de co-ubicación

  • mercoledì 22 luglio 2026·hwupgrade.it

    Addio a settimane di test in laboratorio: ecco il supercomputer NVIDIA che progetta i farmaci da solo

    Bristol Myers Squibb, colosso farmaceutico con sede principale negli Stati Uniti, ha annunciato un secondo NVIDIA DGX SuperPOD basato su otto sistemi DGX Vera Rubin NVL72 che sar�…